![Rachel Leheny](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rachel Leheny
Directeur Général chez
CALCIMEDICA, INC.
Fortune : 331 820 $ au 30/06/2026
Profil
Rachel Anne Leheny is the founder of Valence Life Sciences LLC, founded in 2012, serving as Founding Managing Director.
Dr. Leheny was the founder of Caxton Advantage Venture Partners, founded in 2006, serving as Managing Director.
Current jobs include Chief Executive Officer & Director at CalciMedica Subsidiary, Inc. since 2019, Chief Executive Officer & Director at CalciMedica, Inc. since 2019, Director & Manager at Valence Investments SPV IV LLC, Director at DalCor Pharmaceuticals Canada, Inc., and Member at Advantage Life Sciences Partners LLC.
Former jobs include Managing Director at Hambrecht & Quist Group from 1993 to 1998, Director at Corthera, Inc., Independent Director at Anthera Pharmaceuticals, Inc. in 2011, Senior Vice President at Lehman Brothers, Inc. from 2000 to 2002, Faculty Member at the University of California, Berkeley, Principal at Caxton Health Holdings LLC, Executive Vice President at UBS Warburg, Inc., and Chief Operating Officer at The Clearity Foundation from 2015 to 2017.
Education includes a doctorate from The Trustees of Columbia University in The City of New York conferred in 1991 and undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC. 1,05 % | 25/06/2026 | 322 155 ( 1,05 % ) | 331 820 $ | 30/06/2026 |
Postes actifs de Rachel Leheny
| Sociétés | Poste | Début |
|---|---|---|
| CALCIMEDICA, INC. | Directeur Général | 01/09/2019 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Directeur/Membre du Conseil | - |
Valence Investments SPV IV LLC
 Valence Investments SPV IV LLC BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | - |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Directeur Général | 26/03/2019 |
Valence Life Sciences LLC
 Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of private and micro-cap public drug development companies. It provides financing for late stage capital requirements. | Fondateur | 01/01/2012 |
Advantage Life Sciences Partners LLC | Corporate Officer/Principal | 24/09/2009 |
Anciens postes connus de Rachel Leheny
| Sociétés | Poste | Fin |
|---|---|---|
The Clearity Foundation
 The Clearity Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur des opérations | 01/02/2017 |
Caxton Advantage Venture Partners
 Caxton Advantage Venture Partners Investment ManagersFinance Caxton Advantage Venture Partners invests primarily in companies in the pharmaceutical and biotechnology sectors | Fondateur | - |
| ANTHERA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/02/2011 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Rachel Leheny
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for illnesses in the acute care setting | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caxton Advantage Venture Partners
Caxton Advantage Venture Partners Investment ManagersFinance Caxton Advantage Venture Partners invests primarily in companies in the pharmaceutical and biotechnology sectors | Finance |
Advantage Life Sciences Partners LLC | |
Caxton Health Holdings LLC
 Caxton Health Holdings LLC Financial ConglomeratesFinance Operates as an investment firm | Finance |
UBS Warburg, Inc. | |
The Clearity Foundation
The Clearity Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Valence Life Sciences LLC
Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of private and micro-cap public drug development companies. It provides financing for late stage capital requirements. | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
Valence Investments SPV IV LLC
Valence Investments SPV IV LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Choisissez Zonebourse 
